Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REZAFUNGIN vs RIFABUTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REZAFUNGIN vs RIFABUTIN: Safety Overview

Metric REZAFUNGIN RIFABUTIN
Total FAERS Reports 108 1,586
Deaths Reported 12 158
Death Rate 11.1% 10.0%
Hospitalizations 20 502
Average Patient Age 53.8 yrs 53.2 yrs
% Female Patients 54.3% 53.1%
FDA Approval Date Mar 22, 2023 Dec 17, 2021
Manufacturer Melinta Therapeutics, LLC REMEDYREPACK INC.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription